Contact us   |  

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype

Subnetwork: Red blood cell defects

Disease group/s: Rare constitutional hemolytic anemia due to an enzyme disorder (Other than PKD)

Scope and Purpose: 5. Diagnosis and treatment

Patients' involvement?: No

Rigour of development: A - Evidence and consensus based

Link: https://pubmed.ncbi.nlm.nih.gov/24787449/